UPDATE: JPMorgan Downgrades Actus Medical (AFIB) to Neutral
Tweet Send to a Friend
(Updated - March 19, 2021 4:58 AM EDT)
JPMorgan analyst Robbie Marcus downgraded Actus Medical (NASDAQ: AFIB) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Robbie Marcus downgraded Actus Medical (NASDAQ: AFIB) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
